Baudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000 Apr 25, 2023 8:00am EDT
Baudax Bio to Host Key Opinion Leader Webinar to Discuss Results of Phase 2 BX1000 Trial Apr 24, 2023 4:30pm EDT
Baudax Bio Announces Positive Results from 2nd Interim Analysis of Phase 2 Randomized Trial for BX1000 Mar 27, 2023 8:00am EDT
Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update Feb 23, 2023 8:00am EST
Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000 Jan 24, 2023 8:00am EST
Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery Dec 08, 2022 8:00am EST
